LL-37 (5mg)

LL-37 is a cationic α-helical research peptide derived from the C-terminal region of human cathelicidin (hCAP18). It exhibits broad-spectrum antimicrobial and immunomodulatory activity in preclinical studies, acting via membrane disruption and modulation of TLR/NF-κB pathways. LL-37 is widely used in microbiology and immunology research investigating host defense peptides and innate immune signaling.

For research use only. Not for human consumption.

No claims have been supported by the Food and Drug Administration.